Personal healthcare budgets, can England learn from the Netherlands?
This article was originally published in Scrip
The Department of Health in England is exploring the possibility of personal health budgets to give patients with long term conditions more control over their care. However, a similar system that has been ongoing in the Netherlands for more than a decade is being drastically curbed owing to its lack of sustainability. England must learn from the Netherlands and other countries if it is to avoid the same mistakes with its personal healthcare budget plans, say experts writing in the British Medical Journal online.
You may also be interested in...
The UK's main reimbursement bodies made a series of decisions this week that were broadly favorable and largely focused on oncology medicines.
While troubled Valeant was divesting iNova to private equity investors, Novartis announced a pair of oncology-focused deals, out-licensing a brain cancer drug to Midatech and partnering with IBM Watson Health to optimize breast cancer treatment.
Astellas and Pfizer have amended the PROSPER trial protocol in a bid to position Xtandi ahead of Zytiga in the early stage prostate cancer market.